Metaxalone Tablet
NDC Package 87450-101-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Metaxalone tablets is metaxalone is used to treat muscle spasms/pain. This formulation utilizes a tablet delivery system. Marketed by Highmark Pharma Llc, this product is identified by NDC 87450-101 and is authorized under FDA application ANDA207466.

Identification & Billing

NDC Package Code
87450-101-10
Package Description
100 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
87450010110
RxNorm Crosswalk
RxCUI: 197935 - metaxalone 400 MG Oral Tablet

Clinical Specifications

Proprietary Name
Metaxalone
Non-Proprietary Name
Metaxalone
Substance Name
Metaxalone
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Metaxalone is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment.

Regulatory & Marketing

Labeler Name
Highmark Pharma Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA207466
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-01-2021
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87450-101-10 identifies a specific commercial package of 100 tablet in 1 bottle of Metaxalone, a human prescription drug labeled by Highmark Pharma Llc. This tablet is formulated for oral use and contains metaxalone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Highmark Pharma Llc on November 01, 2021. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Metaxalone is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment.

How is this Highmark Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87450010110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87450-101-10
11-Digit CMS (5-4-2)
87450-0101-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.